(Adnkronos) – PharmaEssentia Corporation, a Taiwan-based biopharmaceutical company, is expanding its global presence through new drug approvals, clinical trials, and overseas investments, seeking to bring its innovative Taiwan-developed drug to more international markets. Founded in Taiwan in 2003 by scientist Dr. Ko-Chung